We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+11.49%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$2.27B
AUM Growth
-$163M
Cap. Flow
-$390M
Cap. Flow %
-17.16%
Top 10 Hldgs %
60.11%
Holding
1,283
New
44
Increased
84
Reduced
363
Closed
631

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$68.4M
2
AMZN icon
Amazon
AMZN
+$32.5M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$25M
4
DAVA icon
Endava
DAVA
+$22.8M
5
MSFT icon
Microsoft
MSFT
+$22.7M

Sector Composition

Rank Sector Weight
1 Technology 27.54%
2 Financials 24.9%
3 Consumer Discretionary 12.74%
4 Communication Services 11.34%
5 Healthcare 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZEPP
1176
Zepp Health
ZEPP
$73.9M
-625
Closed -$20.1K
ZG icon
1177
Zillow
ZG
$8.23B
-337
Closed -$29.9K
QTTB icon
1178
Q32 Bio
QTTB
$447M
-11
Closed -$1.59K
VRN
1179
DELISTED
Veren
VRN
-8,000
Closed -$36.9K
CMBT
1180
CMB.TECH NV
CMBT
$5.32B
-2,000
Closed -$19.5K
GAP
1181
The Gap Inc
GAP
$8.45B
-329
Closed -$7.47K
BNT
1182
Brookfield Wealth Solutions
BNT
$12.3B
$0 ﹤0.01%
9
-78
-90% -$3.13K
INVX
1183
Innovex International
INVX
$2.11B
-1,685
Closed -$42.4K
HURA
1184
TuHURA Biosciences
HURA
$134M
-22
Closed -$32.4K
FLG
1185
Flagstar Bank National Association
FLG
$5.58B
-167
Closed -$6.43K
GRCE
1186
Grace Therapeutics
GRCE
$44.6M
-1
Closed -$6
XIFR
1187
XPLR Infrastructure LP
XIFR
$1.11B
-100
Closed -$7.54K
INFN
1188
DELISTED
Infinera Corporation Common Stock
INFN
-342
Closed -$2.85K
ZUO
1189
DELISTED
Zuora, Inc.
ZUO
-201
Closed -$3.33K
SILV
1190
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
-2,736
Closed -$19.1K
VIRX
1191
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-749
Closed -$6.01K
AKTS
1192
DELISTED
Akoustis Technologies Inc
AKTS
-1,224
Closed -$11.9K
AY
1193
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
-2,000
Closed -$69K
TCS
1194
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
-67
Closed -$9.52K
TFFP
1195
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
-29
Closed -$5.6K
MRO
1196
DELISTED
Marathon Oil Corporation
MRO
-596
Closed -$8.15K
AXNX
1197
DELISTED
Axonics, Inc. Common Stock
AXNX
-930
Closed -$60.5K
DNMR
1198
DELISTED
Danimer Scientific, Inc.
DNMR
-45
Closed -$29.3K
LILM
1199
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
-2,000
Closed -$21K
HYZN
1200
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
-24
Closed -$8.33K

Similar funds

RBC Europe's Q4 2021 Portfolio in Review

As of Q4 2021, RBC Europe held 1,283 positions worth $2.27B, down 6.7% from $2.44B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

RBC Europe withdrew a net $390M in Q4 2021, closing 631 positions and reducing 363 holdings. Its most notable exit was Endava, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, RBC Europe opened a new position in Brown & Brown worth $2.02M.

  • RBC Europe's largest Q4 2021 buy was Brown & Brown: 28,685 shares worth $2.02M.
  • RBC Europe added most to Thermo Fisher Scientific in Q4 2021, an estimated $34.6M increase.
  • RBC Europe's biggest Q4 2021 reduction was Apple, cutting an estimated $68.4M.
  • RBC Europe fully exited Endava in Q4 2021, selling an estimated $22.8M.
  • RBC Europe's ten largest holdings make up 60% of its $2.27B portfolio in Q4 2021.
  • RBC Europe opened 44 new positions and closed 631 in Q4 2021.
  • RBC Europe's portfolio value fell 6.7% quarter-over-quarter to $2.27B.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.